Track topics on Twitter Track topics that are important to you
Tetraphase Pharmaceuticals’ ups and downs have continued, as new data have clouded the future of the Watertown, MA, company’s experimental antibiotic, eravacycline, once again. Tetraphase (NASDAQ: TTPH) reported that eravacycline failed a 1,200-patient Phase 3 study called Ignite3, one of four late-stage trials the company ran to test the antibiotic against either complicated urinary tract […]
Original Article: Mid-FDA Review, Tetraphase Stumbles Again on Latest Phase 3 SetbackNEXT ARTICLE
Benign Prostatic Hyperplasia (BPH) Erectile Dysfunction Urology Urology is the branch of medicine concerned with the urinary tract and diseases that affect it. Examples include urethritis, urethrostenosis and incontinence. Urology is a su...